[ad_1]
Encourage loss-making investors to contact the company before June 18, 2021; click Here Submit trade information
Los Angeles, May 27, 2021 (Global News Agency)- Portnor Law Firm Inform investors that they have represented Emergent BioSolutions, Inc. (NYSE stock code:Electronic Business System) Between investors who acquired shares April 24, 2020 and April 16, 2021Investors must seek to play an active role in this lawsuit before June 18, 2021.
Encourage investors to contact a lawyer Leslie F. Portnoy, To determine your eligibility to participate in this action, please call 310-692-8883 or e-mail, Or click here Join the case.
This New York Times An article was published on March 31, 2021, reporting the accidental contamination of the coronavirus vaccine developed by Johnson & Johnson and AstraZeneca PLC at the Emergent manufacturing plant in Baltimore. According to reports, Associated PressIn April 2020, the U.S. Food and Drug Administration observed in April 2020 that this contaminated Emergent factory experienced a series of mistakes. On April 1, 2021, Emergent’s stock price fell by US$12.45 per share, or 13.4% of the news, and closed at US$80.46 per share.
A class action has been filed. If you wish to be the lead plaintiff, you must relocate the court before June 18, 2021.
Please visit our website View more information and submit your transaction information.
Portnoy Law Firm represented investors in prosecuting lawsuits caused by company misconduct. The company’s founding partners have recovered more than $5.5 billion for victims of investors. Lawyer advertisement. The previous results cannot guarantee similar results.
Lesley F. Portnoy, Esq.
Admitted to the California and New York Bar Association
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Lawyer advertisement
[ad_2]
Source link
